Category: Diagnostic Technologies

Diagnostic Technologies

PathAI Integrates PathExplore on AISight Platform for Tumor Analysis

The self-service integration enables users to analyze tumor microenvironments at single-cell resolution using routine H&E slides.

Diagnostic Technologies

FDA Clears Automated Platform for Multiple Myeloma Diagnosis

The system combines enhanced sensitivity with automation to detect M-proteins at low concentrations, supporting early diagnosis of plasma cell disorders.

Diagnostic Technologies

Can AI Learn to Smell Disease? A New Dataset Paves the Way

Researchers are developing a large-scale olfactory dataset to train artificial intelligence, potentially unlocking smell as a powerful tool for early disease detection.

Anatomic Pathology

Mopec Integrates Lumea’s Tissue Handling Technology Into Grossing Station

The integration is designed to bridge specimen grossing with digital pathology workflows for improved diagnostic accuracy and efficiency.

Digital Pathology

Digital Pathology Market Expected to Reach $6.55 Billion by 2035

Market research projects 17.15% compound annual growth rate driven by AI integration and cloud-based platforms.

Clinical Chemistry

Carolina Liquid Chemistries Alcohol Assay Receives CLIA Moderate Complexity Rating for Abbott ImmTox 270

The ethyl alcohol assay categorization enables moderate complexity laboratories to expand drug screening capabilities on the Abbott analyzer platform.

Flow Cytometry

10x Genomics Launches Next Generation of Chromium Flex to Scale Single-Cell Research

New plate-based multiplexing can profile up to 384 samples and 100 million cells per week.

Hematology & Serology

Blood Test Avoidance Creates Major Gaps in Care, HLTH Panel Finds

With 70% of medical decisions depending on blood testing, experts highlight the toll of missed testing and the promise of alternative collection methods.

Immunoassay

DPYD Genotyping Assay Receives FDA Breakthrough Device Designation

The qPCR-based test detects variants that increase risk of severe fluoropyrimidine chemotherapy toxicity.

Mass Spectrometry

New RNA-seq Kit Enables Direct Processing of 3D Spheroid Models

The extraction-free library preparation technology is designed to deliver full transcriptome coverage for drug screening and toxicology studies.

Microbiology

FDA Clears Enhanced Microbial Identification System Features

New clearances expand MALDI-TOF platform capabilities with improved software, faster sample prep, and broader species coverage.

Molecular Diagnostics

EazeBio Partners with UC Santa Cruz to Develop Instrument-Free Diagnostics

The collaboration will focus on creating a cortisol biosensor for stress and metabolic health testing using luminescent biosensors and AI-guided interpretation.

Point-of-Care

Monod Bio Taps AI Protein Design to Build Rapid Point-of-Care Preeclampsia Test

The Seattle biotech company receives a $750,000 Gates Foundation grant to develop a rapid diagnostic using novel protein binders and a luciferase system.

Urinalysis & Toxicology

How Rapid Diagnostics Are Changing Overdose Response in the Synthetic Opioid Crisis

Faster, more accurate testing is helping clinicians identify synthetic opioids sooner and treat overdoses more effectively.